Issue 7, 2023

Two novel Pd thiosemicarbazone complexes as efficient and selective antitumoral drugs

Abstract

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Palladium complexes can be used as anticancer and pharmacological agents as a promising alternative to overcome the disadvantages of platinum drugs, controlling the speciation in solution and limiting toxicity. In this study, two novel complexes were developed and their speciation in solution was deeply investigated, demonstrating their stability in solution together with their behavior versus nucleic acid models and serum proteins via thermodynamic studies. Furthermore, both complexes were demonstrated to be efficient and more specific than the benchmark cisplatin drug because of their lower toxicity to healthy cells.

Graphical abstract: Two novel Pd thiosemicarbazone complexes as efficient and selective antitumoral drugs

Supplementary files

Article information

Article type
Research Article
Submitted
15 Nov 2022
Accepted
14 Dec 2022
First published
29 Dec 2022
This article is Open Access
Creative Commons BY license

Inorg. Chem. Front., 2023,10, 1986-1998

Two novel Pd thiosemicarbazone complexes as efficient and selective antitumoral drugs

T. Hidalgo, D. Fabra, R. Allende, A. I. Matesanz, P. Horcajada, T. Biver and A. G. Quiroga, Inorg. Chem. Front., 2023, 10, 1986 DOI: 10.1039/D2QI02424A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements